Lionhunter Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.1M Sell
12,171
-200
-2% -$236K 6.28% 1
2026
Q2
$14.8M Buy
+12,371
New +$12.6M 6.69% 1

Other funds holding LLY

Lionhunter Capital Management's LLY Position: Q3 2026 in Review

Lionhunter Capital Management reduced its Eli Lilly (LLY) stake by 1.6% in Q3 2026, selling an estimated $236K and leaving 12,171 shares worth $14.1M. The position accounts for 6.28% of the portfolio, ranked #1.

Lionhunter Capital Management first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $14.8M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Lionhunter Capital Management held 12,171 shares of Eli Lilly worth $14.1M as of Q3 2026.
  • Lionhunter Capital Management sold 200 Eli Lilly shares in Q3 2026, an estimated $236K.
  • Eli Lilly made up 6.28% of Lionhunter Capital Management's portfolio in Q3 2026, its #1 holding.
  • Lionhunter Capital Management first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • Lionhunter Capital Management's Eli Lilly position peaked at $14.8M in Q2 2026.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Lionhunter Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.